NY-ESO-1 immunotherapy for ovarian cancer
26 Apr 2016
NY-ESO-1 immunotherapy for ovarian cancer
Imaging tumour habitats - life at the edge
Normal and neoplastic stem cells
WIN 2016: Preview of themes
Novel agents before and after stem cell transplantation for myeloma
Immunology highlights from the ITOC-3 conference
EBMT 2016 Highlights: Expert discussion
Novel technologies for understanding the repertoire of tumour infiltrating T cells in cancer
Targeting AFP in hepatocellular cancer
Combination of viroimmunotherapy with checkpoint inhibitors
The role of microRNAs in modulation of the immune escape of tumors
T cells expressing two additional receptors (TETARs) for the use in a multiple- hit immunotherapy